462 related articles for article (PubMed ID: 28762306)
1. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
Fatima MT; Islam Z; Ahmad E; Salahuddin P
Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
[TBL] [Abstract][Full Text] [Related]
2. Walking the tightrope: proteostasis and neurodegenerative disease.
Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
4. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
5. The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders.
Di Domenico F; Lanzillotta C
Adv Protein Chem Struct Biol; 2022; 132():49-87. PubMed ID: 36088079
[TBL] [Abstract][Full Text] [Related]
6. Molecular chaperones biochemistry and role in neurodegenerative diseases.
Chaari A
Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
[TBL] [Abstract][Full Text] [Related]
7. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
Sinnige T; Yu A; Morimoto RI
Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
Khanam H; Ali A; Asif M; Shamsuzzaman
Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
[TBL] [Abstract][Full Text] [Related]
9. Molecular Chaperones in Neurodegenerative Diseases: A Short Review.
Bobori C; Theocharopoulou G; Vlamos P
Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461
[TBL] [Abstract][Full Text] [Related]
10. Role of molecular chaperones in neurodegenerative disorders.
Meriin AB; Sherman MY
Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
[TBL] [Abstract][Full Text] [Related]
11. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
Dohm CP; Kermer P; Bähr M
Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
[TBL] [Abstract][Full Text] [Related]
12. Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.
Bose S; Cho J
Ageing Res Rev; 2017 May; 35():155-175. PubMed ID: 27702699
[TBL] [Abstract][Full Text] [Related]
13. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
14. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Maiti P; Manna J; Veleri S; Frautschy S
Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
16. Protein-misfolding diseases and chaperone-based therapeutic approaches.
Chaudhuri TK; Paul S
FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
[TBL] [Abstract][Full Text] [Related]
17. Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.
Carver JA; Ecroyd H; Truscott RJW; Thorn DC; Holt C
Acc Chem Res; 2018 Mar; 51(3):745-752. PubMed ID: 29442498
[TBL] [Abstract][Full Text] [Related]
18. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
[TBL] [Abstract][Full Text] [Related]
19. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
Muchowski PJ
Neuron; 2002 Jul; 35(1):9-12. PubMed ID: 12123602
[TBL] [Abstract][Full Text] [Related]
20. Quality control of the proteins associated with neurodegenerative diseases.
Gao X; Hu H
Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):612-8. PubMed ID: 18604452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
